How quick is weight loss with Wegovy, really?

The first few weeks: quieter appetite before the scales move much

Picture yourself three days into your first Wegovy pen. The number on the scale has barely shifted. But something feels different, you stopped halfway through dinner and felt satisfied, which almost never happened before. That early experience is not imagination. Semaglutide begins engaging GLP-1 receptors quickly, slowing how fast the stomach empties and signalling fullness to the brain. The physiological effect starts well before the weight loss is visible.

Practically speaking, a useful habit during those early weeks is weighing yourself on the same day each week, at the same time of day, without clothes. Day-to-day fluctuations from water retention or digestion can disguise real progress. One weekly reading per week, logged consistently, gives you a cleaner picture over a month than daily weighing does.

Nausea is the most commonly reported side effect at this stage, typically linked to dose increases rather than ongoing use. Most people find it settles within days, especially if they eat smaller portions and avoid high-fat meals. The NHS medicines page for semaglutide covers what to expect and when to contact a prescriber.

Months one to three: when the numbers start to reflect what you feel

This is the window most people remember as the turning point. The dose is increasing toward 1mg or 1.7mg during this period, and with it the appetite suppression tends to deepen. Published data from the STEP 1 trial in the New England Journal of Medicine showed participants losing an average of roughly 6% of body weight within the first 12 weeks, before the maintenance dose was even reached.

Weight loss at this stage is rarely perfectly linear. Some weeks produce no movement at all. Others see two or three kilograms drop. Both are normal. What matters is the trend across four to six weeks, not any single weigh-in. If you are curious about how quickly you see weight loss with Wegovy, people with a higher starting BMI often see faster early movement simply because a percentage of a larger number is itself larger, which does not mean results will be weaker later.

For a closer look at how weight loss tends to unfold across the first four weeks specifically, the one-month Wegovy results page walks through what the evidence and clinical experience suggest for that earliest stretch.

Months three to twelve: the maintenance phase and where most of the loss accumulates

Once the 2.4mg maintenance dose is reached, many people find weight loss continues steadily for the remainder of the first year. The STEP 1 trial ran for 68 weeks; that is over a year. The average 15% reduction at the end of that period was not mostly front-loaded, meaningful loss continued well into the second half of the trial.

There is a plateau dynamic worth understanding. Semaglutide reduces appetite; it cannot override the fact that as weight falls, the body needs fewer calories to function. This is biology, not failure. The prescriber-led review built into any clinical programme exists partly to address this, whether through dose optimisation, lifestyle adjustments, or both. For those whose weight loss slows significantly even at maintenance, the MHRA-approved 7.2mg single-dose pen now offers an additional option, with trial data showing approximately 20.7% average loss over 72 weeks.

Understanding the full timeline (and how results compare at different points) is something our clinical team is asked about regularly, and patients often want to know how quickly they can expect to see results with Wegovy before they begin. The guide to how long Wegovy takes to work goes into the dose-by-dose timeline in more detail.

What influences speed, and what no trial can predict for you individually

Clinical trials report averages. Your result will not be average, it will be yours. Several factors shape how quickly weight loss happens with Wegovy: starting BMI, adherence to the dose schedule, what you eat alongside treatment, how much activity you add, whether you experience significant GI side effects, and how your body metabolises the medicine.

The cost of treatment is a practical consideration for many people. The treatment options page sets out what is included at nume (consultation, prescription, delivery and aftercare) so there are no surprises further down the line.

One thing the evidence is clear on: stopping early is the biggest barrier to the results the trials demonstrate. Many people also ask how soon they will see weight loss with Wegovy, and the honest answer is that meaningful change typically requires staying the course for several months rather than weeks. NICE guidance on semaglutide, published at NICE TA875, reflects this by situating Wegovy within a wider weight management approach rather than as a standalone intervention.

If you are weighing up whether Wegovy is the right option, or want to understand which dose pathway fits your circumstances, speaking to a prescriber is the practical next step. Our guide to how fast Wegovy weight loss tends to be can also help set realistic expectations before you begin. Speak to our prescribers through a free consultation, reviewed the same day by a real clinician, with no waiting list.